Biphasic ER-α36-mediated estrogen signaling regulates growth of gastric cancer cells

被引:20
作者
Wang, Xuming [1 ,2 ]
Huang, Xuan [1 ,2 ]
Fu, Zhengqi [1 ,2 ]
Zou, Feng [1 ,2 ]
Li, Yan [1 ,2 ]
Wang, Zhaoyi [3 ]
Liu, Lijiang [1 ,2 ]
机构
[1] Jianghan Univ, Sch Med, Dept Pathol & Pathophysiol, Wuhan 430056, Hubei, Peoples R China
[2] Jianghan Univ, Jiangda Pathol Inst, Dept Pathol, Wuhan 430056, Hubei, Peoples R China
[3] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA
基金
中国国家自然科学基金;
关键词
gastric cancer; estrogen; ER-alpha; 36; Cyclin D1; D-TYPE CYCLINS; RECEPTOR-ALPHA; BETA; DIFFERENTIATION; CARCINOGENESIS; VARIANT; D1;
D O I
10.3892/ijo.2014.2660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To examine the expression patterns of ER-alpha 36 and Cyclin D1 in human gastric cancer tissues and to investigate the effects of ER-alpha 36-mediated estrogen signaling on the growth of gastric cancer cells, 117 samples of formalin-fixed and paraffin-embedded gastric cancer tumor tissues and 40 fresh gastric cancer tumor tissues were analyzed with immunohistochemistry assay and western blot analysis. ER-alpha 36 expression was well correlated with gender (male:female ratio 2.88:1, P=0.01), invasion to serosa (P=0.01) as well as Cyclin D1 expression (P<0.01). The effects of different concentrations of estrogen on the growth of different gastric cancer cells and normal gastric cells as well as gastric cancer SGC7901 cells with different levels of ER-alpha 36 expression were examined. SGC7901 cells with high levels of ER-alpha 36 expression exhibited estrogen hypersensitivity, high growth rate and high levels of Cyclin D1 expression while SGC7901 cells with knocked-down levels of ER-alpha 36 expression were insensitive to estrogen stimulation, grew slowly and expressed less Cyclin D1. Our results indicate that ER-alpha 36 mediates biphasic estrogen signaling in the growth of gastric cancer cells.
引用
收藏
页码:2325 / 2330
页数:6
相关论文
共 21 条
  • [1] Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach
    Arber, N
    Gammon, MD
    Hibshoosh, H
    Britton, JA
    Zhang, Y
    Schonberg, JB
    Roterdam, H
    Fabian, I
    Holt, PR
    Weinstein, IB
    [J]. HUMAN PATHOLOGY, 1999, 30 (09) : 1087 - 1092
  • [2] The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel
    Bar-Sela, Gil
    Hershkovitz, Dov
    Haim, Nissim
    Kaidar-Person, Orit
    Shulman, Katerina
    Ben-Izhak, Ofer
    [J]. ONCOLOGY LETTERS, 2013, 5 (02) : 559 - 563
  • [3] Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23
  • [4] Oestrogen and the enigmatic male predominance of gastric cancer
    Chandanos, Evangelos
    Lagergren, Jesper
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (16) : 2397 - 2403
  • [5] Hepatocyte nuclear factor 1α and β control terminal differentiation and cell fate commitment in the gut epithelium
    D'Angelo, Anna
    Bluteau, Olivier
    Garcia-Gonzalez, Miguel A.
    Gresh, Lionel
    Doyen, Antonia
    Garbay, Serge
    Robine, Sylvie
    Pontoglio, Marco
    [J]. DEVELOPMENT, 2010, 137 (09): : 1573 - 1582
  • [6] A variant of estrogen receptor-α, ER-α36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis
    Deng, Hao
    Huang, Xuan
    Fan, Jun
    Wang, Liubai
    Xia, Qin
    Yang, Xiuping
    Wang, Zhaoyi
    Liu, Lijiang
    [J]. ONCOLOGY REPORTS, 2010, 24 (01) : 171 - 176
  • [7] Involvement of ER-α36 in the malignant growth of gastric carcinoma cells is associated with GRP94 overexpression
    Fu, Zhengqi
    Deng, Hao
    Wang, Xuming
    Yang, Xiuping
    Wang, Zhaoyi
    Liu, Lijiang
    [J]. HISTOPATHOLOGY, 2013, 63 (03) : 325 - 333
  • [8] FURUKAWA H, 1982, CANCER RES, V42, P5181
  • [9] Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells
    Glassford, Janet
    Rabin, Neil
    Lam, Eric W. -F.
    Yong, Kwee L.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (02) : 243 - 254
  • [10] Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107, 10.3322/caac.21492]